Back to 
Pacer Advisors, Inc.
Pacer Advisors, Inc.GSGSK1
Showing 0 of 16 quarters
Position history for Pacer Advisors, Inc.'s holdings in GLAXOSMITHKLINE PLC-SPON ADR
As of its Q2 2022 13F, Pacer Advisors held 290,909 shares of GSK1 (Glaxosmithkline), worth $12.7M. Pacer Advisors' 13F filings listed GSK1 from Q2 2020 to Q2 2022, 9 quarterly filings. GSK1 was 0.1% of Pacer Advisors' reported 13F portfolio.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.